23.19
Finanzdaten der Collegium Pharmaceutical Inc-Aktie (COLL)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
3.29%
199.88
|
193.52 | 205.45 | 209.36 | 188.00 |
| Cost Of Revenue |
17.45%
89.59
|
76.27 | 77.07 | 80.19 | 79.62 |
| Gross Profit |
5.93%
110.29
|
117.25 | 128.38 | 129.17 | 108.38 |
| Operating Expenses |
23.44%
106.59
|
86.35 | 67.62 | 67.08 | 73.28 |
| Operating Income/Loss |
88.03%
3.698
|
30.90 | 60.76 | 62.09 | 35.10 |
| Income/Loss From Continuing Operations Before Tax |
172.21%
-13.53
|
18.74 | 29.04 | 43.44 | 17.02 |
| Income Tax Expense/Benefit, Deferred |
639.15%
-7.155
|
-0.968 | -10.07 | -12.13 | -2.914 |
| Income Tax Expense/Benefit |
64.21%
1.519
|
4.244 | 12.07 | 11.93 | 5.042 |
| Net Income/Loss |
203.83%
-15.05
|
14.50 | 16.96 | 31.51 | 11.98 |
| Basic Average Shares |
1.16%
32.46
|
32.09 | 31.65 | 31.57 | 31.81 |
| Diluted Average Shares |
18.98%
32.46
|
40.07 | 40.08 | 39.44 | 39.08 |
| Basic Earnings Per Share |
202.22%
-0.46
|
0.45 | 0.54 | 1.00 | 0.38 |
| Diluted Earnings Per Share |
215.00%
-0.46
|
0.40 | 0.46 | 0.84 | 0.34 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):